Publication:
Bcl-2 Expression in Skin Pathergy Reaction of Behçet's Disease

dc.authorscopusid6602733678
dc.authorscopusid6603682965
dc.authorscopusid35579498900
dc.authorscopusid22945639700
dc.authorscopusid6603561910
dc.contributor.authorSüllü, Y.
dc.contributor.authorŞentürk, N.
dc.contributor.authorYíldíz, L.
dc.contributor.authorSüllü, Y.D.
dc.contributor.authorTuranli, A.Y.
dc.date.accessioned2020-06-21T15:49:28Z
dc.date.available2020-06-21T15:49:28Z
dc.date.issued2001
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Süllü] Ýüksel, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Şentürk] Nilgün, Department of Dermatology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yíldíz] Levent, Department of Pathology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Süllü] Yurdanur Demirel, Department of Pathology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Turanli] Ahmet Yaşar, Department of Dermatology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractBackground: Bcl-2 expression in leukocytes plays an important role in autoimmune and inflammatory disease. Objective: In the present study, we investigated the Bcl-2 expression in the skin pathergy reaction (SPR) of Behçet's disease (BD). Methods: The skin pathergy test (SPT) was performed on 23 patients with BD and 7 healthy controls. After 48 h, SPT specimens were taken by punch biopsy. Control samples were also obtained from the normal skin of 7 patients with BD and 11 patients with BD-unrelated leukocytoclastic vasculitis. Biopsy specimens were evaluated by routine histopathological examination and immunohistochemical Bcl-2 staining. Results: The SPT was clinically positive in 9 of 23 patients and histopathologically positive in 13 but never in the healthy controls. The majority of leukocytes in 12 of 13 histopathologically positive specimens were stained with Bcl-2. Only 3 BD-unrelated leukocytoclastic vasculitis samples showed Bcl-2 positivity. No Bcl-2 staining was found in healthy controls and normal skin samples of patients with BD. Conclusion: Our data may suggest a role of Bcl-2-mediated inflammation in the pathogenesis of the SPR in BD. Copyright © 2001 S. Karger AG, Basel.en_US
dc.identifier.doi10.1159/000051605
dc.identifier.endpage93en_US
dc.identifier.issn1018-8665
dc.identifier.issn1421-9832
dc.identifier.issue2en_US
dc.identifier.pmid11306827
dc.identifier.scopus2-s2.0-0035054628
dc.identifier.scopusqualityQ1
dc.identifier.startpage90en_US
dc.identifier.urihttps://doi.org/10.1159/000051605
dc.identifier.volume202en_US
dc.identifier.wosWOS:000168122400003
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofDermatologyen_US
dc.relation.journalDermatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBcl-2en_US
dc.subjectBehçet's Diseaseen_US
dc.subjectLeukocytoclastic Vasculitisen_US
dc.subjectSkin Pathergy Reactionen_US
dc.titleBcl-2 Expression in Skin Pathergy Reaction of Behçet's Diseaseen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files